scholarly journals Acquired Arteriovenous Fistula of the Breast Following Ultrasound Guided Biopsy of Invasive Ductal Carcinoma

2013 ◽  
Vol 3 ◽  
pp. 38 ◽  
Author(s):  
Adam Gregg ◽  
Rebecca Leddy ◽  
Madelene Lewis ◽  
Abid Irshad
Keyword(s):  
Arteriovenous Fistula ◽  
Invasive Ductal Carcinoma ◽  
Breast Biopsy ◽  
Ductal Carcinoma ◽  
Breast Mass ◽  
Large Core ◽  
Ultrasound Guided ◽  
Case Patient ◽  
Image Guided ◽  
Sonographic Evaluation

Image guided large-core breast biopsies are commonly performed procedures with relatively rare complications. The majority of these complications are minor, though at times more significant vascular injuries can occur with these biopsies as demonstrated by this case. Patient developed a pulsatile vascular breast mass after an ultrasound guided breast biopsy of invasive ductal carcinoma. Sonographic evaluation of this new breast mass demonstrated this mass to represent an arteriovenous fistula (AVF). Though multiple therapies are available for an iatrogenic fistula within the breast, the AVF was surgically excised in this case as it was immediately adjacent to a known cancer.

scholarly journals Intraductal Papilloma Without Atypia on Image- Guided Breast Biopsy: Upgrade Rates to Carcinoma at Surgical Excision

Breast Care ◽  
2018 ◽  
Vol 13 (5) ◽  
pp. 364-368 ◽  
Author(s):  
Doris Leithner ◽  
Benjamin Kaltenbach ◽  
Petra Hödl ◽  
Volker Möbus ◽  
Volker Brandenbusch ◽  
...  
Keyword(s):  
Needle Biopsy ◽  
Breast Biopsy ◽  
Ductal Carcinoma ◽  
Statistical Tests ◽  
Menopausal Status ◽  
Surgical Excision ◽  
Lesion Size ◽  
Intraductal Papilloma ◽  
Image Guided ◽  
Institutional Review

Background: The management of intraductal papilloma without atypia (IDP) in breast needle biopsy remains controversial. This study investigates the upgrade rate of IDP to carcinoma and clinical and radiologic features predictive of an upgrade. Methods: Patients with a diagnosis of IDP on image-guided (mammography, ultrasound, magnetic resonance imaging) core needle or vacuum-assisted biopsy and surgical excision of this lesion at a certified breast center between 2007 and 2017 were included in this institutional review board-approved retrospective study. Appropriate statistical tests were performed to assess clinical and radiologic characteristics associated with an upgrade to malignancy at excision. Results: For 60 women with 62 surgically removed IDPs, the upgrade rate to malignancy was 16.1% (10 upgrades, 4 invasive ductal carcinoma, 6 ductal carcinoma in situ). IDPs with upgrade to carcinoma showed a significantly greater distance to the nipple (63.5 vs. 36.8 mm; p = 0.012). No significant associations were found between upgrade to carcinoma and age, menopausal status, lesion size, microcalcifications, BI-RADS descriptors, initial BI-RADS category, and biopsy modality. Conclusion: The upgrade rate at excision for IDPs diagnosed with needle biopsy was higher than expected according to some guideline recommendations. Observation only might not be appropriate for all patients with IDP, particularly for those with peripheral IDP.

Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ as Revealed by Large-Core Needle Breast Biopsy

2000 ◽  
Vol 175 (5) ◽  
pp. 1341-1346 ◽  
Author(s):  
Marla L. Rosenfield Darling ◽  
Darrell N. Smith ◽  
Susan C. Lester ◽  
Carolyn Kaelin ◽  
Donna-Lee G. Selland ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Breast Biopsy ◽  
Ductal Carcinoma ◽  
Atypical Ductal Hyperplasia ◽  
Large Core ◽  
Core Needle ◽  
Ductal Hyperplasia

scholarly journals Breast Cancer Development in a Transgender Male Receiving Testosterone Therapy

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Nadia Barghouthi ◽  
Jennifer Turner ◽  
Jessica Perini
Keyword(s):  
Breast Cancer ◽  
Invasive Ductal Carcinoma ◽  
Breast Biopsy ◽  
Ductal Carcinoma ◽  
Growth Factor Receptor ◽  
Premenopausal Women ◽  
Left Breast ◽  
Bilateral Mastectomy ◽  
Testosterone Therapy ◽  
Increased Risk

Context. To describe a case of invasive ductal carcinoma of the breast in a transgender male receiving testosterone therapy for gender-affirming treatment. Case Description. A 28-year-old transgender male receiving intramuscular testosterone was found to have a breast mass on ultrasound after self-exam revealed a palpable breast lump. Ultrasound-guided breast biopsy revealed estrogen receptor/progesterone receptor (ER/PR) negative, human epidermal growth factor receptor-2 (HER-2) positive, invasive ductal carcinoma of the left breast. He underwent neoadjuvant and adjuvant chemotherapy along with bilateral mastectomy. At patient request, his testosterone injections were permanently discontinued. Conclusion. Fewer than 20 cases of breast cancer in transgender male patients have been reported in medical literature. While studies have shown increased risk of breast cancer in postmenopausal women with higher testosterone levels, data regarding premenopausal women is conflicting and little is known about breast cancer risk in transgender individuals receiving gender-affirming hormone therapy (GAHT), with inconclusive results regarding correlation between testosterone therapy and breast cancer. More research is required to evaluate whether a possible increased risk of breast cancer exists for transgender men receiving gender-affirming therapy.

scholarly journals Ultrasound-guided Cryoablation of Invasive Ductal Carcinoma inside the MR Room

2010 ◽  
Vol 9 (1) ◽  
pp. 31-36 ◽  
Author(s):  
Mitsuhiro TOZAKI ◽  
Eisuke FUKUMA ◽  
Takako SUZUKI ◽  
Kazuei HOSHI
Keyword(s):  
Invasive Ductal Carcinoma ◽  
Ductal Carcinoma ◽  
Ultrasound Guided

Accuracy of ultrasound-guided, large-core needle breast biopsy

2008 ◽  
Vol 18 (9) ◽  
pp. 1761-1773 ◽  
Author(s):  
G. Schueller ◽  
C. Schueller-Weidekamm ◽  
T. H. Helbich
Keyword(s):  
Breast Biopsy ◽  
Large Core ◽  
Ultrasound Guided ◽  
Core Needle

Ultrasound-Guided Core Biopsy

2018 ◽  
Author(s):  
Philip A. Di Carlo
Keyword(s):  
Core Biopsy ◽  
Breast Biopsy ◽  
Excisional Biopsy ◽  
Ultrasound Guided ◽  
Needle Localization ◽  
Image Guided ◽  
Guided Biopsy ◽  
Multiple Imaging ◽  
Key Points

Prior to 1993, when ultrasound-guided core breast biopsy was first described by Parker and colleagues, surgery following image-guided needle localization was necessary to obtain a histological diagnosis of breast lesions. But there are many financial, practical, and clinical advantages of image-guided core biopsy over surgical excisional biopsy. There are also many advantages to ultrasound-guided biopsy over stereotactic- or MRI-guided biopsy, detailed in this chapter. Ultrasound is now usually the modality of choice by which to perform core biopsies if the lesion is visualized by multiple imaging modalities. This chapter, appearing in the section on interventions and surgical changes, reviews the key points of performing ultrasound-guided core biopsy. Topics discussed include protocols for both spring-loaded and vacuum-assisted devices; pre-procedure and post-procedure management, and imaging follow-up.

Sign in / Sign up

Export Citation Format

Share Document